3D bioprinting of human pluripotent stem cells for tissue engineering

Will Shu, Alan John Faulkner-Jones

Research output: Contribution to journalConference Contribution

Abstract

In recent years, the use of a simple inkjet technology for cell printing has triggered tremendous interest in the field of 3d biofab-rication or organ printing. A key challenge has been the development of printing processes which are both controllable and less harmful, in order to preserve cell and tissue viability and functions. In this talk, we will present the development of a valve-based stem cell printer that has been validated to print highly viable and functional human embryonic stem cells (h-ESCs) and induced pluripotent stem cells (h- iPSCs). 3D bioprinting based on both scaffold based (using different printable hydrogel materials) and scaffold-free (using hanging droplet technique) approaches will be discussed. This work demonstrates that the valve-based printing process is gentle enough to maintain stem cell viability, accurate enough to produce spheroids of uniform size and cell-containing hydrogel structures, and that printed cells maintain their pluripotency. In addition, our recent work on printing human stem cell derived liver tissues for animal-free drug testing applications will be presented.
LanguageEnglish
PagesS390-S390
Number of pages1
JournalTissue Engineering, Parts A, B & C
Volume21
Issue numberPart A
DOIs
Publication statusPublished - 1 Sep 2015

Fingerprint

Stem cells
Tissue engineering
Printing
Hydrogel
Hydrogels
Scaffolds
Tissue
Liver
Animals
Testing
Pharmaceutical Preparations

Keywords

  • stem cell printing
  • tissue engineering
  • pluripotent stem cells

Cite this

Shu, Will ; Faulkner-Jones, Alan John. / 3D bioprinting of human pluripotent stem cells for tissue engineering. In: Tissue Engineering, Parts A, B & C. 2015 ; Vol. 21, No. Part A. pp. S390-S390.
@article{9dbe0fe1366b472bae9ad56c88b4aa1e,
title = "3D bioprinting of human pluripotent stem cells for tissue engineering",
abstract = "In recent years, the use of a simple inkjet technology for cell printing has triggered tremendous interest in the field of 3d biofab-rication or organ printing. A key challenge has been the development of printing processes which are both controllable and less harmful, in order to preserve cell and tissue viability and functions. In this talk, we will present the development of a valve-based stem cell printer that has been validated to print highly viable and functional human embryonic stem cells (h-ESCs) and induced pluripotent stem cells (h- iPSCs). 3D bioprinting based on both scaffold based (using different printable hydrogel materials) and scaffold-free (using hanging droplet technique) approaches will be discussed. This work demonstrates that the valve-based printing process is gentle enough to maintain stem cell viability, accurate enough to produce spheroids of uniform size and cell-containing hydrogel structures, and that printed cells maintain their pluripotency. In addition, our recent work on printing human stem cell derived liver tissues for animal-free drug testing applications will be presented.",
keywords = "stem cell printing, tissue engineering, pluripotent stem cells",
author = "Will Shu and Faulkner-Jones, {Alan John}",
year = "2015",
month = "9",
day = "1",
doi = "10.1089/ten.tea.2015.5000.abstract",
language = "English",
volume = "21",
pages = "S390--S390",
journal = "Tissue Engineering, Parts A, B & C",
issn = "2152-4947",
number = "Part A",

}

3D bioprinting of human pluripotent stem cells for tissue engineering. / Shu, Will; Faulkner-Jones, Alan John.

In: Tissue Engineering, Parts A, B & C, Vol. 21, No. Part A, 01.09.2015, p. S390-S390.

Research output: Contribution to journalConference Contribution

TY - JOUR

T1 - 3D bioprinting of human pluripotent stem cells for tissue engineering

AU - Shu, Will

AU - Faulkner-Jones, Alan John

PY - 2015/9/1

Y1 - 2015/9/1

N2 - In recent years, the use of a simple inkjet technology for cell printing has triggered tremendous interest in the field of 3d biofab-rication or organ printing. A key challenge has been the development of printing processes which are both controllable and less harmful, in order to preserve cell and tissue viability and functions. In this talk, we will present the development of a valve-based stem cell printer that has been validated to print highly viable and functional human embryonic stem cells (h-ESCs) and induced pluripotent stem cells (h- iPSCs). 3D bioprinting based on both scaffold based (using different printable hydrogel materials) and scaffold-free (using hanging droplet technique) approaches will be discussed. This work demonstrates that the valve-based printing process is gentle enough to maintain stem cell viability, accurate enough to produce spheroids of uniform size and cell-containing hydrogel structures, and that printed cells maintain their pluripotency. In addition, our recent work on printing human stem cell derived liver tissues for animal-free drug testing applications will be presented.

AB - In recent years, the use of a simple inkjet technology for cell printing has triggered tremendous interest in the field of 3d biofab-rication or organ printing. A key challenge has been the development of printing processes which are both controllable and less harmful, in order to preserve cell and tissue viability and functions. In this talk, we will present the development of a valve-based stem cell printer that has been validated to print highly viable and functional human embryonic stem cells (h-ESCs) and induced pluripotent stem cells (h- iPSCs). 3D bioprinting based on both scaffold based (using different printable hydrogel materials) and scaffold-free (using hanging droplet technique) approaches will be discussed. This work demonstrates that the valve-based printing process is gentle enough to maintain stem cell viability, accurate enough to produce spheroids of uniform size and cell-containing hydrogel structures, and that printed cells maintain their pluripotency. In addition, our recent work on printing human stem cell derived liver tissues for animal-free drug testing applications will be presented.

KW - stem cell printing

KW - tissue engineering

KW - pluripotent stem cells

U2 - 10.1089/ten.tea.2015.5000.abstract

DO - 10.1089/ten.tea.2015.5000.abstract

M3 - Conference Contribution

VL - 21

SP - S390-S390

JO - Tissue Engineering, Parts A, B & C

T2 - Tissue Engineering, Parts A, B & C

JF - Tissue Engineering, Parts A, B & C

SN - 2152-4947

IS - Part A

ER -